|
Subcutaneous epcoritamab (SC epcor) administered outpatient (outpt) for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL): Results from phase 2 EPCORE NHL-6. |
| |
|
Consulting or Advisory Role - Abbvie/Genentech; AstraZeneca; Bristol-Myers Squibb/Celgene; Novartis |
Research Funding - Abbvie; Bristol-Myers Squibb/Celgene; Epizyme; Novartis |
| |
|
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Genmab; Incyte; Janssen; Rigel |
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Daiichi Sankyo; Genentech; Genmab; Incyte; Janssen; Rigel |
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Genmab; Incyte; Janssen; Karyopharm Therapeutics; Regeneron; Rigel; Sanofi |
Research Funding - Amgen; AstraZeneca; Daiichi Sankyo; Genentech; Incyte; Janssen; Rigel |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - GlaxoSmithKline; Janssen Oncology; Janssen Oncology (Inst); Karyopharm Therapeutics; Sanofi; TG Therapeutics |
| |
|
|
Consulting or Advisory Role - Janssen |
| |
|
Stock and Other Ownership Interests - Karyopharm Therapeutics |
Consulting or Advisory Role - Ipsen |
| |
Fernando Manuel Vargas Madueno |
Consulting or Advisory Role - Ipsen; Janssen |
| |
|
Consulting or Advisory Role - Kite, a Gilead company |
Travel, Accommodations, Expenses - Kite, a Gilead company |
| |
|
Honoraria - ADC Therapeutics; Janssen Biotech; Janssen Biotech; Millennium; Sanofi |
Consulting or Advisory Role - Millennium; Sanofi |
Speakers' Bureau - Onclive |
Research Funding - Genentech/Roche (Inst) |
| |
|
Consulting or Advisory Role - AbbVie |
| |
|
No Relationships to Disclose |
| |
|
|
| |
|
|
Stock and Other Ownership Interests - Abbvie |
| |
|
|
Stock and Other Ownership Interests - Abbvie |
| |
|
|
Stock and Other Ownership Interests - Abbvie |
| |
|
|
Stock and Other Ownership Interests - Genmab |
| |
|
Employment - US Oncology Network |
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Beigene; Bristol-Myers Squibb; Genentech; Janssen Oncology; Lilly; Merck |